ADPGK and neoplasm: Therefore, we assessed the growth, differentiation status and various markers for tumour aggressiveness in Ramos BL cells and their ADPGK knock-out counterparts, upon activation with a known protein kinase-C (PKC) based inducer of B-cell activation, phorbol 12-myristate 13-acetate (PMA)21–26.